CTGF as potential therapeutic target in microbiota-driven colorectal carcinogenesis. »
10/28/25

Patients with HER2+ and TN MBC with BM had improved rwOS. »
10/28/25

Patients with IFITM3-positive tumors experienced shorter progression-free survival on osimertinib treatment. »
10/28/25

ISOC platforms simulate dynamic immune cell activity, cytokine signaling and antigen presentation. »
10/28/25

Pre-treatment sarcopenia did not affect survival but was linked to longer hospital stays. »
10/28/25

Lifestyle changes, as measured by HLI, not significantly associated. »
10/29/25

Model demonstrated exceptional accuracy in distinguishing advanced adenomas from benign cases. »
10/29/25

Shift towards healthier BMI may contribute to breast cancer prevention. »
10/29/25

Co-culture of spheroids expressing lower levels of PODXL resulted in more NK cell infiltration and cytotoxicity. »
10/30/25

High-level C promoter methylation in EBV-associated tumors. »
10/30/25